Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study | Zendy

Andrew J. Cutler | Zendy; Katsumi Suzuki | Zendy; Brittney Starling | Zendy; Kanan Balakrishnan | Zendy; Marina Komaroff | Zendy; Mariacristina Castelli | Zendy; Suzanne Meeves | Zendy; Ann Childress | Zendy

Open Access

Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study

Author(s) -

Andrew J. Cutler,

Katsumi Suzuki,

Brittney Starling,

Kanan Balakrishnan,

Marina Komaroff,

Mariacristina Castelli,

Suzanne Meeves,

Ann Childress

Publication year - 2022

Publication title -

journal of child and adolescent psychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.935

H-Index - 84

eISSN - 1557-8992

pISSN - 1044-5463

DOI - 10.1089/cap.2021.0107

Subject(s) - placebo , medicine , dextroamphetamine , attention deficit hyperactivity disorder , transdermal , clinical endpoint , confidence interval , crossover study , anesthesia , randomized controlled trial , adverse effect , psychiatry , pharmacology , alternative medicine , amphetamine , pathology , dopamine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research